A pharmacologic basis for peripheral vascular resistance changes with contrast media injections.
D000100:Acetrizoic Acid / Q000494:pharmacology; D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D003287:Contrast Media / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D003864:Depression, Chemical; D003973:Diatrizoate / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D004285:Dogs; D005947:Glucose / Q000494:pharmacology; D006614:Hindlimb; D006982:Hypertonic Solutions / Q000494:pharmacology; D007269:Injections, Intra-Arterial; D007458:Iodipamide / Q000494:pharmacology; D007483:Iothalamic Acid / Q000494:pharmacology; D009995:Osmosis / Q000187:drug effects*; D010275:Parasympathetic Nervous System / Q000187:drug effects*; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012965:Sodium Chloride / Q000494:pharmacology; D014294:Trimethaphan / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology*
D003287:Contrast Media; D006982:Hypertonic Solutions; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D003973:Diatrizoate; D007483:Iothalamic Acid; D000100:Acetrizoic Acid; D012965:Sodium Chloride; D014294:Trimethaphan; D001285:Atropine; D004155:Diphenhydramine; D011433:Propranolol; D005947:Glucose; D000109:Acetylcholine; D007458:Iodipamide